Genus Capital Management’s Ambev ABEV Stock Holding History

Genus Capital Management’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Hold	66,608	–	–	0.02%	197
2026 Q1	$194K	Sell	66,608 -5,000	-7%	-$14.3K	0.02%	185
2025 Q4	$177K	Hold	71,608	–	–	0.02%	191
2025 Q3	$160K	Buy	71,608 +10,000	+16%	+$22.9K	0.02%	199
2025 Q2	$148K	Sell	61,608 -4,392	-7%	-$10.7K	0.02%	178
2025 Q1	$154K	Buy	+66,000	New	+$132K	0.02%	177
2024 Q2	–	Sell	-40,000	Closed	-$91.1K	–	194
2024 Q1	$99.2K	Buy	+40,000	New	+$104K	0.01%	193

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Genus Capital Management's ABEV Position: Q2 2026 in Review

Genus Capital Management held its Ambev (ABEV) position steady in Q2 2026 at 66,608 shares worth $209K. The position accounts for 0.02% of the portfolio, ranked #197.

Genus Capital Management first reported a position in ABEV in Q1 2024 and has held it in 7 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

Genus Capital Management held 66,608 shares of Ambev worth $209K as of Q2 2026.
Genus Capital Management left its Ambev share count unchanged in Q2 2026.
Ambev made up 0.02% of Genus Capital Management's portfolio in Q2 2026, its #197 holding.
Genus Capital Management first reported a position in Ambev in Q1 2024 and has held it in 7 quarters since.
403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.